CN114487209A - 基于磁性固相萃取的脂溶性维生素的液相色谱串联质谱检测方法 - Google Patents
基于磁性固相萃取的脂溶性维生素的液相色谱串联质谱检测方法 Download PDFInfo
- Publication number
- CN114487209A CN114487209A CN202210227412.3A CN202210227412A CN114487209A CN 114487209 A CN114487209 A CN 114487209A CN 202210227412 A CN202210227412 A CN 202210227412A CN 114487209 A CN114487209 A CN 114487209A
- Authority
- CN
- China
- Prior art keywords
- phase extraction
- solid phase
- magnetic solid
- fat
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002414 normal-phase solid-phase extraction Methods 0.000 title claims abstract description 112
- 239000011782 vitamin Substances 0.000 title claims abstract description 66
- 229940088594 vitamin Drugs 0.000 title claims abstract description 64
- 229930003231 vitamin Natural products 0.000 title claims abstract description 64
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 64
- 238000001514 detection method Methods 0.000 title claims abstract description 22
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 title claims abstract description 22
- 239000000945 filler Substances 0.000 claims abstract description 85
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000012360 testing method Methods 0.000 claims abstract description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 177
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 46
- 238000002156 mixing Methods 0.000 claims description 41
- 239000000243 solution Substances 0.000 claims description 38
- 239000011259 mixed solution Substances 0.000 claims description 34
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 31
- 239000007864 aqueous solution Substances 0.000 claims description 18
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 16
- 238000004140 cleaning Methods 0.000 claims description 16
- 239000011709 vitamin E Substances 0.000 claims description 16
- 229940045997 vitamin a Drugs 0.000 claims description 16
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 15
- 229930003427 Vitamin E Natural products 0.000 claims description 15
- 239000003480 eluent Substances 0.000 claims description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 15
- 235000019165 vitamin E Nutrition 0.000 claims description 15
- 229940046009 vitamin E Drugs 0.000 claims description 15
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 14
- 235000019155 vitamin A Nutrition 0.000 claims description 14
- 239000011719 vitamin A Substances 0.000 claims description 14
- 239000012086 standard solution Substances 0.000 claims description 10
- 230000004913 activation Effects 0.000 claims description 9
- 239000012071 phase Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 7
- 239000012498 ultrapure water Substances 0.000 claims description 6
- 238000004949 mass spectrometry Methods 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 3
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 claims description 3
- SVWLIIFHXFGESG-UHFFFAOYSA-N formic acid;methanol Chemical group OC.OC=O SVWLIIFHXFGESG-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 239000007788 liquid Substances 0.000 abstract description 8
- 238000001819 mass spectrum Methods 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 4
- 238000001179 sorption measurement Methods 0.000 abstract description 4
- 239000006185 dispersion Substances 0.000 abstract description 3
- 239000011159 matrix material Substances 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 12
- 239000011710 vitamin D Substances 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000000622 liquid--liquid extraction Methods 0.000 description 10
- 238000000638 solvent extraction Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 7
- 229930003316 Vitamin D Natural products 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 235000019166 vitamin D Nutrition 0.000 description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 description 6
- 229940046008 vitamin d Drugs 0.000 description 6
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 description 5
- 235000021318 Calcifediol Nutrition 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 230000006920 protein precipitation Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000013076 target substance Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002552 multiple reaction monitoring Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 description 1
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 description 1
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 description 1
- KJKIIUAXZGLUND-ICCVIKJNSA-N 25-hydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C KJKIIUAXZGLUND-ICCVIKJNSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000000187 Abnormal Reflex Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000018083 Bone metabolism disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 206010021089 Hyporeflexia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- WWDMJSSVVPXVSV-YCNIQYBTSA-N retinyl ester Chemical compound CC1CCCC(C)(C)C1\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O WWDMJSSVVPXVSV-YCNIQYBTSA-N 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
洗脱液溶剂组成 | 25(OH)D<sub>2</sub> | 25(OH)D<sub>3</sub> | VA | VE |
乙腈 | 20144 | 65244 | 196241 | 4025698 |
甲醇 | 30257 | 90545 | 302648 | 4989570 |
乙腈/甲醇(1/1) | 25832 | 80996 | 230826 | 4406725 |
甲醇/异丙醇(9/1) | 40219 | 174232 | 307507 | 5757981 |
甲醇/异丙醇(7/3) | 63219 | 190580 | 677325 | 5930353 |
甲醇/异丙醇(6/4) | 64015 | 195029 | 704765 | 6545505 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210227412.3A CN114487209A (zh) | 2022-03-08 | 2022-03-08 | 基于磁性固相萃取的脂溶性维生素的液相色谱串联质谱检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210227412.3A CN114487209A (zh) | 2022-03-08 | 2022-03-08 | 基于磁性固相萃取的脂溶性维生素的液相色谱串联质谱检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114487209A true CN114487209A (zh) | 2022-05-13 |
Family
ID=81486742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210227412.3A Pending CN114487209A (zh) | 2022-03-08 | 2022-03-08 | 基于磁性固相萃取的脂溶性维生素的液相色谱串联质谱检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114487209A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115586281A (zh) * | 2022-10-31 | 2023-01-10 | 天津智谱仪器有限公司 | 血清25-羟基维生素d的提取系统、方法及联合lc-msms检测法 |
CN115902071A (zh) * | 2023-02-23 | 2023-04-04 | 北京华大吉比爱生物技术有限公司 | 检测样品中脂溶性维生素的方法 |
CN116026971A (zh) * | 2023-03-30 | 2023-04-28 | 苏州颐坤生物科技有限公司 | 一种用于人血清和血浆中全谱脂溶性维生素及其代谢物检测的试剂盒及检测方法 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE630261A (zh) * | ||||
WO2009115352A1 (de) * | 2008-03-19 | 2009-09-24 | Florian Schweigert | Verfahren zur extraktion und zum nachweis von fettlöslichen inhaltsstoffen aus biologischen materialien |
CN108645942A (zh) * | 2018-06-20 | 2018-10-12 | 杭州凯莱谱精准医疗检测技术有限公司 | 血清中25-羟基维生素d的高效液相色谱串联质谱检测方法 |
CN108776185A (zh) * | 2018-07-24 | 2018-11-09 | 曲阜师范大学 | 一种含羟基的胆固醇及其代谢物的检测分析方法 |
CN109212091A (zh) * | 2018-10-24 | 2019-01-15 | 天津国科医工科技发展有限公司 | 血清中25-羟基维生素d液相色谱串联质谱联用检测方法及试剂盒 |
CN109675343A (zh) * | 2018-12-07 | 2019-04-26 | 天津迪沃特生物电子科技有限公司 | 一种萃取和/或净化的方法及装置 |
CN110174476A (zh) * | 2019-06-10 | 2019-08-27 | 合肥谱佳医学检验实验室有限公司 | 一种干血片中多种脂溶性维生素的液相色谱串联质谱的检测方法 |
CN110542735A (zh) * | 2019-09-12 | 2019-12-06 | 贝知(上海)医疗科技有限公司 | 超高效液相质谱联用高通量测定多种脂溶性维生素的方法 |
CN111208248A (zh) * | 2020-01-14 | 2020-05-29 | 南京品生医学检验实验室有限公司 | 一种超高效液相色谱串联质谱法检测血清中5种脂溶性维生素的方法 |
CN111366646A (zh) * | 2020-02-27 | 2020-07-03 | 苏州新波生物技术有限公司 | 一种基于免疫纯化结合质谱检测的25-羟维生素d分析方法 |
CN112067388A (zh) * | 2020-09-07 | 2020-12-11 | 苏州英芮诚生化科技有限公司 | 一种血浆中脂溶性维生素高通量检测前处理方法、试剂盒 |
US20210190733A1 (en) * | 2019-12-18 | 2021-06-24 | Xi'an Jiaotong University | Method for simultaneously determining fat-soluble vitamins and carotenoids in serum |
CN113063871A (zh) * | 2021-03-24 | 2021-07-02 | 杭州佰勤医疗器械有限公司 | 一种代谢小分子检测方法及检测系统 |
CN113391008A (zh) * | 2021-02-03 | 2021-09-14 | 杭州凯莱谱精准医疗检测技术有限公司 | 一种基于自动化移液工作站进行脂溶性维生素检测样本前处理的方法 |
CN113419017A (zh) * | 2021-05-25 | 2021-09-21 | 郑州安图生物工程股份有限公司 | 生物样品中小分子物质检测的前处理试剂 |
-
2022
- 2022-03-08 CN CN202210227412.3A patent/CN114487209A/zh active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE630261A (zh) * | ||||
WO2009115352A1 (de) * | 2008-03-19 | 2009-09-24 | Florian Schweigert | Verfahren zur extraktion und zum nachweis von fettlöslichen inhaltsstoffen aus biologischen materialien |
CN108645942A (zh) * | 2018-06-20 | 2018-10-12 | 杭州凯莱谱精准医疗检测技术有限公司 | 血清中25-羟基维生素d的高效液相色谱串联质谱检测方法 |
CN108776185A (zh) * | 2018-07-24 | 2018-11-09 | 曲阜师范大学 | 一种含羟基的胆固醇及其代谢物的检测分析方法 |
CN109212091A (zh) * | 2018-10-24 | 2019-01-15 | 天津国科医工科技发展有限公司 | 血清中25-羟基维生素d液相色谱串联质谱联用检测方法及试剂盒 |
CN109675343A (zh) * | 2018-12-07 | 2019-04-26 | 天津迪沃特生物电子科技有限公司 | 一种萃取和/或净化的方法及装置 |
CN110174476A (zh) * | 2019-06-10 | 2019-08-27 | 合肥谱佳医学检验实验室有限公司 | 一种干血片中多种脂溶性维生素的液相色谱串联质谱的检测方法 |
CN110542735A (zh) * | 2019-09-12 | 2019-12-06 | 贝知(上海)医疗科技有限公司 | 超高效液相质谱联用高通量测定多种脂溶性维生素的方法 |
US20210190733A1 (en) * | 2019-12-18 | 2021-06-24 | Xi'an Jiaotong University | Method for simultaneously determining fat-soluble vitamins and carotenoids in serum |
CN111208248A (zh) * | 2020-01-14 | 2020-05-29 | 南京品生医学检验实验室有限公司 | 一种超高效液相色谱串联质谱法检测血清中5种脂溶性维生素的方法 |
CN111366646A (zh) * | 2020-02-27 | 2020-07-03 | 苏州新波生物技术有限公司 | 一种基于免疫纯化结合质谱检测的25-羟维生素d分析方法 |
CN112067388A (zh) * | 2020-09-07 | 2020-12-11 | 苏州英芮诚生化科技有限公司 | 一种血浆中脂溶性维生素高通量检测前处理方法、试剂盒 |
CN113391008A (zh) * | 2021-02-03 | 2021-09-14 | 杭州凯莱谱精准医疗检测技术有限公司 | 一种基于自动化移液工作站进行脂溶性维生素检测样本前处理的方法 |
CN113063871A (zh) * | 2021-03-24 | 2021-07-02 | 杭州佰勤医疗器械有限公司 | 一种代谢小分子检测方法及检测系统 |
CN113419017A (zh) * | 2021-05-25 | 2021-09-21 | 郑州安图生物工程股份有限公司 | 生物样品中小分子物质检测的前处理试剂 |
Non-Patent Citations (1)
Title |
---|
李启;梅少林;胡红瑶;徐峻卿;: "快速溶剂萃取-超高效液相色谱串联质谱法同时测定干香菇中维生素A、D_2和D_3", 中国卫生检验杂志, no. 07 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115586281A (zh) * | 2022-10-31 | 2023-01-10 | 天津智谱仪器有限公司 | 血清25-羟基维生素d的提取系统、方法及联合lc-msms检测法 |
CN115902071A (zh) * | 2023-02-23 | 2023-04-04 | 北京华大吉比爱生物技术有限公司 | 检测样品中脂溶性维生素的方法 |
CN116026971A (zh) * | 2023-03-30 | 2023-04-28 | 苏州颐坤生物科技有限公司 | 一种用于人血清和血浆中全谱脂溶性维生素及其代谢物检测的试剂盒及检测方法 |
CN116026971B (zh) * | 2023-03-30 | 2024-01-26 | 苏州颐坤生物科技有限公司 | 一种用于人血清和血浆中全谱脂溶性维生素及其代谢物检测的试剂盒及检测方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114487209A (zh) | 基于磁性固相萃取的脂溶性维生素的液相色谱串联质谱检测方法 | |
CN111366671B (zh) | 同时检测血清中18种类固醇激素的化学衍生-超高效液相色谱-串联质谱法 | |
Priego Capote et al. | Identification and determination of fat‐soluble vitamins and metabolites in human serum by liquid chromatography/triple quadrupole mass spectrometry with multiple reaction monitoring | |
CN110487943B (zh) | 一种检测血液样品中脂溶性维生素的方法 | |
EP2510339B1 (en) | Mass spectrometric determination of non-derivatized, non-metabolized vitamin d | |
CN114487210B (zh) | 基于磁性固相萃取的类固醇激素的液相色谱串联质谱检测方法 | |
Dettmer et al. | Amino acid analysis in physiological samples by GC–MS with propyl chloroformate derivatization and iTRAQ–LC–MS/MS | |
CN114324619B (zh) | 一种测定粮谷中咪鲜胺及其代谢物残留量的方法及应用 | |
US20240174700A1 (en) | Layered superhydrophilic ti-cu-mofs, preparation method and use thereof | |
WO2014152502A1 (en) | Method for determining derivatized analytes in a separated biological fluid | |
CN114428138B (zh) | 基于磁性固相萃取的儿茶酚胺及其代谢物的液相色谱串联质谱检测方法 | |
CN112697906A (zh) | 一种检测托法替布手性中间体及其对映异构体的方法 | |
CN112611827A (zh) | 同时检测血清中3种雌激素的化学衍生-超高效液相色谱-串联质谱法 | |
Liu et al. | Simultaneous determination of fourteen β2-agonist enantiomers in food animal muscles by liquid chromatography coupled with tandem mass spectrometry | |
Yu et al. | Magnetic solid-phase extraction based on GO/Fe3O4 coupled with UPLC-MS/MS for determining nitroimidazoles and their metabolites in honey | |
Wang et al. | Efficient extraction and sensitive LC-MS quantification of hydroxytyrosol in wine, oil and plasma | |
Li et al. | Novel filter-press single-step cleanup approach facilitated rapid screening and accurate quantification of 112 veterinary drugs in aquatic products | |
Zheng et al. | Quantitative analysis of total methenolone in animal source food by liquid chromatography‐tandem mass spectrometry | |
CN114544836A (zh) | 检测痕量雌激素、17-羟孕烯醇酮、醛固酮、硫酸脱氢表雄酮的前处理方法及检测方法 | |
Xuan et al. | Determination of vitamin A in blood serum based on solid‐phase extraction using cetyltrimethyl ammonium bromide‐modified attapulgite | |
CN115586281A (zh) | 血清25-羟基维生素d的提取系统、方法及联合lc-msms检测法 | |
Ludovici et al. | Principles, current applications, and future perspectives of liquid chromatography-mass spectrometry in clinical chemistry | |
CN114755321A (zh) | 血清中脂溶性维生素的检测方法 | |
EP1695095B1 (en) | Method for the determination of 25-hydroxycholecalciferol in feed | |
CN116106451A (zh) | 高效液相色谱连用检测人血中的脂溶性维生素技术 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Country or region after: China Address after: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant after: Tianjin Guoke Medical Technology Development Co.,Ltd. Address before: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant before: TIANJIN GUOKE YIGONG TECHNOLOGY DEVELOPMENT Co.,Ltd. Country or region before: China |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240325 Address after: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant after: Tianjin Guoke Medical Technology Development Co.,Ltd. Country or region after: China Applicant after: Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Address before: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant before: Tianjin Guoke Medical Technology Development Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right |